The Anti-Melanoma Activity of Dinaciclib, a Cyclin-Dependent Kinase Inhibitor, Is Dependent on p53 Signaling

Although cyclin dependent kinase (CDK)-2 is known to be dispensable for the growth of most tumors, it is thought to be important for the proliferation of melanoma cells, where its expression is controlled by the melanocyte-lineage specific transcription factor MITF. Treatment of a panel of melanoma...

Descripción completa

Detalles Bibliográficos
Autores principales: Desai, Brijal M., Villanueva, Jessie, Nguyen, Thierry-Thien K., Lioni, Mercedes, Xiao, Min, Kong, Jun, Krepler, Clemens, Vultur, Adina, Flaherty, Keith T., Nathanson, Katherine L., Smalley, Keiran S. M., Herlyn, Meenhard
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2013
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3601112/
https://www.ncbi.nlm.nih.gov/pubmed/23527225
http://dx.doi.org/10.1371/journal.pone.0059588

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3601112/
https://www.ncbi.nlm.nih.gov/pubmed/23527225
http://dx.doi.org/10.1371/journal.pone.0059588

Ejemplares similares